106 research outputs found
Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy
No full textBackground
Intrahepatic cholestasis of pregnancy is a pregnancy-specific liver disorder, possibly associated with an increased risk of severe fetal adverse events. Total serum bile acids (TSBA) concentration, alone or in combination with serum aminotransferases, have been the most often used biomarkers for the diagnosis of intrahepatic cholestasis of pregnancy in clinical practice. Serum bile acid profile, composed of primary or secondary, conjugated or non-conjugated bile acids, may provide more specific disease information.
Objectives
To assess and compare, independently or in combination, the diagnostic accuracy of total serum bile acids or serum bile acids profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy in pregnant women, presenting with pruritus. To define the optimal cut-off values for components of serum bile acid profile; to investigate possible sources of heterogeneity.
Search methods
We searched the Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register, the Cochrane Library, MEDLINE Ovid, Embase Ovid, Science Citation Index Expanded, Conference Proceedings Citation Index - Science, BIOSIS, CINAHL, two Chinese databases (CKNI, VIP), Latin American and Caribbean Health Sciences Literature (LILACS), Scientific Electronic Library Online (SciELO), Evidence Search: Health and Social Care by the National Institute for Health and Care Excellence (NICE), the World Health Organization (WHO) Reproductive Health Library (RHL), and the Turning Research into Practice database (TRIP). The most recent date of search was 6 May 2019. We identified additional references by handsearching the references of articles, meta-analyses, and evidence-based guidelines retrieved from the computerised databases, online trial registries, and grey literature through OpenSIGLE, National Technical Information Service (NTIS), ProQuest Dissertations & Thesis Database, and Index to Theses in Great Britain and Ireland.
Selection criteria
Prospective or retrospective diagnostic case-control or cross-sectional studies, irrespective of publication date, format, and language, which evaluated the diagnostic accuracy of total serum bile acids (TSBA) or components of serum bile acid profile for the diagnosis of intrahepatic cholestasis of pregnancy in pregnant women of any age or ethnicity, in any clinical setting, symptomatic for pruritus.
Data collection and analysis
We selected studies by reading titles, abstracts, or full texts, and assessing their fulfilment of our inclusion criteria. We emailed primary authors to request missing data or individual participant data. Having extracted data from each included study, we built the two-by-two tables for each primary study and for all the index tests considered. We estimated sensitivity and specificity with their 95% confidence intervals (CI). We presented data in coupled forest plots, showing sensitivities and specificities of each study, and we plotted the studies in the Receiver Operating Characteristic (ROC) space. We performed meta-analyses adopting the hierarchical summary ROC model (HSROC) or the bivariate model to meta-analyse the data. We made indirect comparisons of the considered index tests by adding the index tests as covariates to the bivariate or HSROC models. We performed heterogeneity analysis and sensitivity analysis on studies assessing TSBA accuracy. We used Review Manager 5 (RevMan 5) and SAS statistical software, release 9.4 (SAS Institute Inc., Cary, NC, USA), to perform all statistical analyses. We used QUADAS-2 domains to assess the risk of bias of the included studies.
Main results
Our search yielded 5073 references, but at the end of our selection process, only 16 studies fulfilled the review inclusion criteria. Nine of these provided individual participant data. We analysed only data concerning TSBA, cholic acid (CA), glycocholic acid (GCA), chenodeoxycholic acid (CDCA), and CA/CDCA because the remaining planned index tests were assessed in few studies. Only one study had low risk of bias in all four QUADAS-2 domains. The most biased domains were the patient sampling and the reference standard domains. When considering all studies with a cut-off of 10 mu mol/L, TSBA overall sensitivity ranged from 0.72 to 0.98 and specificity ranged from 0.81 to 0.97. After a sensitivity analysis excluding case-control studies, TSBA sensitivity ranged from 0.48 to 0.66 and specificity from 0.52 to 0.99. After a sensitivity analysis excluding studies in which TSBA was part of the reference standard, TSBA sensitivity ranged from 0.49 to 0.65 and specificity from 0.53 to 0.99. We found the estimates of the overall accuracy for some serum bile acid components (CA, GCA, CDCA, and CA/CDCA) to be imprecise, with the CI for sensitivity and specificity very wide or impossible to calculate. Indirect comparisons between serum bile acid profile components and TSBA were not statistically significant. None of the heterogeneity analysis performed was statistically significant, except for the timing of assessment of TSBA (onset of symptoms, peak value among multiple assessments, delivery) but without clinically relevant results. We could not analyse the diagnostic accuracy of combinations of index tests because none of the included studies carried them out, and because of the small number of included studies.
Authors' conclusions
The overall high risk of bias, the existing concern regarding applicability of the results in clinical practice, and the great heterogeneity of the results in the included studies prevents us from making recommendations and reaching definitive conclusions at the present time. Thus, we do not find any compelling evidence to recommend or refute the routine use of any of these tests in clinical practice. So far, the diagnostic accuracy of TSBA for intrahepatic cholestasis of pregnancy might have been overestimated. There were too few studies to permit a precise estimate of the accuracy of serum bile acid profile components. Further primary clinical research is mandatory. We need both further phase II and phase III diagnostic studies
Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy
No full textThis is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the diagnostic accuracy of total serum bile acids or total serum bile acids profile, or both for the diagnosis of intrahepatic cholestasis of pregnancy in pregnant women presenting with pruritus. To compare the diagnostic accuracy of total serum bile acids and each component of serum bile acid profile, considered independently or in combination, in diagnosing intrahepatic cholestasis of pregnancy; to define the optimal cut-off values for these; and to investigate possible sources of heterogeneity
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
No full textBackground: Hepatocellular carcinoma (HCC) occurs mostly in people with chronic liver disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer deaths for men. Despite that abdominal ultrasound (US) is used as an initial test to exclude the presence of focal liver lesions and serum alpha-foetoprotein (AFP) measurement may raise suspicion of HCC occurrence, further testing to confirm diagnosis as well as staging of HCC is required. Current guidelines recommend surveillance programme using US, with or without AFP, to detect HCC in high-risk populations despite the lack of clear benefits on overall survival. Assessing the diagnostic accuracy of US and AFP may clarify whether the absence of benefit in surveillance programmes could be related to under-diagnosis. Therefore, assessment of the accuracy of these two tests for diagnosing HCC in people with chronic liver disease, not included in surveillance programmes, is needed. Objectives: Primary: the diagnostic accuracy of US and AFP, alone or in combination, for the diagnosis of HCC of any size and at any stage in adults with chronic liver disease, either in a surveillance programme or in a clinical setting. Secondary: to assess the diagnostic accuracy of abdominal US and AFP, alone or in combination, for the diagnosis of resectable HCC; to compare the diagnostic accuracy of the individual tests versus the combination of both tests; to investigate sources of heterogeneity in the results. Search methods: We searched the Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic-Test-Accuracy Studies Register, Cochrane Library, MEDLINE, Embase, LILACS, Science Citation Index Expanded, until 5 June 2020. We applied no language or document-type restrictions. Selection criteria: Studies assessing the diagnostic accuracy of US and AFP, independently or in combination, for the diagnosis of HCC in adults with chronic liver disease, with cross-sectional and case-control designs, using one of the acceptable reference standards, such as pathology of the explanted liver, histology of resected or biopsied focal liver lesion, or typical characteristics on computed tomography, or magnetic resonance imaging, all with a six-months follow-up. Data collection and analysis: We independently screened studies, extracted data, and assessed the risk of bias and applicability concerns, using the QUADAS-2 checklist. We presented the results of sensitivity and specificity, using paired forest-plots, and tabulated the results. We used a hierarchical meta-analysis model where appropriate. We presented uncertainty of the accuracy estimates using 95% confidence intervals (CIs). We double-checked all data extractions and analyses. Main results: We included 373 studies. The index-test was AFP (326 studies, 144,570 participants); US (39 studies, 18,792 participants); and a combination of AFP and US (eight studies, 5454 participants). We judged at high-risk of bias all but one study. Most studies used different reference standards, often inappropriate to exclude the presence of the target condition, and the time-interval between the index test and the reference standard was rarely defined. Most studies with AFP had a case-control design. We also had major concerns for the applicability due to the characteristics of the participants. As the primary studies with AFP used different cut-offs, we performed a meta-analysis using the hierarchical-summary-receiver-operating-characteristic model, then we carried out two meta-analyses including only studies reporting the most used cut-offs: around 20 ng/mL or 200 ng/mL. AFP cut-off 20 ng/mL: for HCC (147 studies) sensitivity 60% (95% CI 58% to 62%), specificity 84% (95% CI 82% to 86%); for resectable HCC (six studies) sensitivity 65% (95% CI 62% to 68%), specificity 80% (95% CI 59% to 91%). AFP cut-off 200 ng/mL: for HCC (56 studies) sensitivity 36% (95% CI 31% to 41%), specificity 99% (95% CI 98% to 99%); for resectable HCC (two studies) one with sensitivity 4% (95% CI 0% to 19%), specificity 100% (95% CI 96% to 100%), and one with sensitivity 8% (95% CI 3% to 18%), specificity 100% (95% CI 97% to 100%). US: for HCC (39 studies) sensitivity 72% (95% CI 63% to 79%), specificity 94% (95% CI 91% to 96%); for resectable HCC (seven studies) sensitivity 53% (95% CI 38% to 67%), specificity 96% (95% CI 94% to 97%). Combination of AFP (cut-off of 20 ng/mL) and US: for HCC (six studies) sensitivity 96% (95% CI 88% to 98%), specificity 85% (95% CI 73% to 93%); for resectable HCC (two studies) one with sensitivity 89% (95% CI 73% to 97%), specificity of 83% (95% CI 76% to 88%), and one with sensitivity 79% (95% CI 54% to 94%), specificity 87% (95% CI 79% to 94%). The observed heterogeneity in the results remains mostly unexplained, and only in part referable to different cut-offs or settings (surveillance programme compared to clinical series). The sensitivity analyses, excluding studies published as abstracts, or with case-control design, showed no variation in the results. We compared the accuracy obtained from studies with AFP (cut-off around 20 ng/mL) and US: a direct comparison in 11 studies (6674 participants) showed a higher sensitivity of US (81%, 95% CI 66% to 90%) versus AFP (64%, 95% CI 56% to 71%) with similar specificity: US 92% (95% CI 83% to 97%) versus AFP 89% (95% CI 79% to 94%). A direct comparison of six studies (5044 participants) showed a higher sensitivity (96%, 95% CI 88% to 98%) of the combination of AFP and US versus US (76%, 95% CI 56% to 89%) with similar specificity: AFP and US 85% (95% CI 73% to 92%) versus US 93% (95% CI 80% to 98%). Authors' conclusions: In the clinical pathway for the diagnosis of HCC in adults, AFP and US, singularly or in combination, have the role of triage-tests. We found that using AFP, with 20 ng/mL as a cut-off, about 40% of HCC occurrences would be missed, and with US alone, more than a quarter. The combination of the two tests showed the highest sensitivity and less than 5% of HCC occurrences would be missed with about 15% of false-positive results. The uncertainty resulting from the poor study quality and the heterogeneity of included studies limit our ability to confidently draw conclusions based on our results
Abdominal ultrasound and alpha-fetoprotein for the diagnosis of hepatocellular carcinoma
No full textThis is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To assess the diagnostic accuracy of abdominal ultrasound and alpha-fetoprotein (AFP), alone or in combination, for the diagnosis of hepatocellular carcinoma (HCC) of any size and at any stage in people with chronic advanced liver disease, either in a surveillance programme or in a clinical setting
Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
No full textSandra Milic,1 Ivana Mikolasevic,1,2 Irena Krznaric-Zrnic,1 Marija Stanic,3 Goran Poropat,1 Davor Stimac,1 Vera Vlahovic-Palcevski,4 Lidija Orlic2 1Department of Gastroenterology, UHC Rijeka, Rijeka, Croatia; 2Department of Nephrology, Dialysis and Kidney Transplantation, UHC Rijeka, Rijeka, Croatia; 3Department of Hematology, UHC Rijeka, Rijeka, Croatia; 4Department for Clinical Pharmacology, University of Rijeka Medical School, UHC Rijeka, Rijeka, Croatia Abstract: Diet and lifestyle changes have led to worldwide increases in the prevalences of obesity and metabolic syndrome, resulting in substantially greater incidence of nonalcoholic fatty liver disease (NAFLD). NAFLD is considered a hepatic manifestation of metabolic syndrome and is related to diabetes, insulin resistance, central obesity, hyperlipidemia, and hypertension. Nonalcoholic steatohepatitis (NASH) is an entity that describes liver inflammation due to NAFLD. Growing evidence suggests that NAFLD is a multisystem disease with a clinical burden that is not only confined to liver-related morbidity and mortality, but that also affects several extra-hepatic organs and regulatory pathways. Thus, NAFLD is considered an important public health issue, but there is currently no effective therapy for all NAFLD patients in the general population. Studies seeking optimal therapy for NAFLD and NASH have not yet led to development of a universal protocol for treating this growing problem. Several pharmacological agents have been studied in an effort to improve insulin resistance and the proinflammatory mediators that may be responsible for NASH progression. Cardiovascular risk factors are highly prevalent among NASH patients, and the backbone of treatment regimens for these patients still comprises general lifestyle interventions, including dietary changes and increased physical activity. Vitamin E and thiazolidinedione derivatives are currently the most evidence-based therapeutic options, but only limited clinical evidence is available regarding their long-term efficacy and safety. Vitamin D and renin–angiotensin–aldosterone system blockers are promising drugs that are currently being intensively investigated for use in NAFLD/NASH patients. Keywords: nonalcoholic fatty liver disease, therapy, metabolic syndrome, insulin resistanc
Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements
No full textTo examine the temporal changes of both controlled attenuation parameter (CAP) and liver stiffness measurements (LSM), assessed by Fibroscan, in a large sample of patients with non-alcoholic fatty liver disease (NAFLD)
000204
No full textSTRANA 4Dan bratstva i jedinstva
Proslava 12-godisnj- ice julskih ustanaka u Jugoslaviji - 86-godisnji- ce Kanade
Juzno - ontarijski distriktni piknik
SAVEZA IUGOSLAVENSKIH KANADJANA NEDELJA
o+Z rv " вмввНЗ
r $ bFSI
JOHN BOYD
Вввг" Ш?
— J
bbbbbbbbbbbLibb bLE--
X
SIMEON CVETKOV
BBBBBBBLSLh. '!B?&BввBВ
vBBBBBv 4BW VBBhI
IVAN STIMAC
-
K 0 N G E R T
IGRE
644 - HBZ kod Highway 20)
ЛЛ4
SPORT
BIRANJE POPULARNE DJEVOJKE
POPULARNE
PLES
(Zemljiste odsjeka
JOHN BOYD,
ckrctar Kanadsko?
Slavcnskoc Komitcta
SIMEON CVETKOV,
urcdnik tnakcdonsko?
lita --Novo Vrcmc
IVAN STIMAC,
upravitclj "Jedintva
JULA
Mountain Park Hamilton
PROGRAMU.
GOVORNICI
НГL вввввв1внв1ввшНвввв9вввввНв ЈСВввввввввНвж. f h&jAH : Ш1ВШШШШт jhki J5S4!
HI К~ж 1% J- Bl- mЖ. Шш S BakaB; JH Ж?ж Wl Wi?T Ш aV КЛ --Ж _ ЧјЈи жLJkPv Ш'ЈЈ itP VyvI
I 1?Вв#Ч5ПЧРш ' bbbbI "и - вС_ AiIl_LiI V ZrT ' 1Лл вввН bMbbbbbHbIbH
YMzxl!'' т1и LH LbbbbLI f T#. C.V --АЛ il --IkIbMHI w;iLsm аВВВВВВВв1 BBBBBBBBBBBK——'— J &bbbbbbbbbbbk£i4b4[ ввввввввввВн (!►- -' Ж. £2 =VHaMV ———P— кшг.т',! r n " " 'ТЗ&ВВВВВВВВВВВВа 1 1 1 ii mi тШШШШШШШШШШШШШШвВШШтЛгЈтЛаашШШШШШШШШШШШШ
Tamburaski zbor "SLOHODA ♦
IXFORMAC1JE O TRAXSPORTOVAXJU :
Autobus! voze iz slijedecih mjesta:
TORONTO: Autobus! krecu ispred hale na 386 Ontario ulice u
10.30, a ispred stanice na Sunnyside u 11 sat! prije podne.
HAMILTON: Autobus! krecu sa ugla James ! Barton ulice u
12.30, a ispred hale na 243 Beach Road u 1 sat poslije podne.
PORT COLBORNE I WELLANDi Autobus! krecu Sz
Port Colbome ispred United Church na Mitchell ulic! u 10.30, a ispred
Fire Hall u Crowlandu u 11 sati prije podne.
BSBBBBKiBBBBBr "ввИвж вВвва7ввввввв7 З bSZ aBBrBBBBL
шЧЈШШи--) ш јввШвВ 'ЈвГ Ч
ЈвИРвЧЖ ,Г - St 17 ?. bbbbW
д__м. . м . , . ВМВЈВЈ Prizor sa proIogodinje? Dana Bratstva i Jedinstvi SVI NAM DOBRO DOSLI!
Precision navigation for aerospace applications
No full textThesis (S.M.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2004.Vita.Includes bibliographical references (p. 162). Includes bibliographical references (p. 162).This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.Navigation is important in a variety of aerospace applications, and commonly uses a blend of GPS and inertial sensors. In this thesis, a navigation system is designed, developed, and tested. Several alternatives are discussed, but the ultimate design is a loosely-coupled Extended Kalman Filter using rigid body dynamics as the process with a small angle linearization of quaternions. Simulations are run using real flight data. A bench top hardware prototype is tested. Results show good performance and give a variety of insights into the design of navigation systems. Special attention is given to convergence and the validity of linearization.by Andrew K. Stimac.S.M
Novi rimski vojnički natpis iz Novog Naselja kod Pakraca
No full textIn autumn 1989. Sasa Radesic, then a student of 7th grade of the Primary school in Pakrac, found a Roman gravestone on the field of Marinko Vujkovic, in Novo Naselje near Pakrac. The gravestone was excavated together with the base and on 25th February 1990. it was transported into the Primary school in Pakrac, where it still is (Bojcic, T., 1990., Sokac-Stimac, D.,
1993., 11) (Pictures 1 and 2).
His brothers and heritors Exorat, quintus and Sur Casii raised the epitaph in ten lines for Casius Sextus, soldier of five hundred Moorish cohorts.
The position of the finding place is very interesting. It is situated at the entrance into Pakra valley, across the earlier finding place of the similar gravestone in
Brusnik in 1913. (Hoffiller, V., Saria, B., 1938., 273-274.) The author thinks that maybe a smaller squad of that unit was placed there, displaced from the camp at the Danube limes ( Lussonium? - Dunakomlod -Barkoczi 1964, no. 147/2) for the protection of important road Siscia - Mursa along which the weapons and equipment to Roman camps on the limes were transported (Bojanovski, I., 1982., 106-122; Bulat, M.,
1989., 36-38). The arrival of the above-mentioned and thousand Moorish unit into Pannonia, and the time of the above mentioned epitaph would be the end of the 2nd and the beginning of the 3rd century (Mocsy, A.,
1962., 623). All the questions will be answered only after further research
- …
